Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Hold
5,975
0.35% 47
2025
Q4
$629K Hold
5,975
0.29% 63
2025
Q3
$501K Hold
5,975
0.24% 75
2025
Q2
$473K Buy
5,975
+1,820
+44% +$145K 0.23% 80
2025
Q1
$373K Sell
4,155
-3,020
-42% -$282K 0.22% 88
2024
Q4
$714K Buy
7,175
+1,620
+29% +$167K 0.4% 42
2024
Q3
$631K Hold
5,555
0.35% 53
2024
Q2
$688K Hold
5,555
0.4% 45
2024
Q1
$733K Hold
5,555
0.44% 41
2023
Q4
$606K Hold
5,555
0.41% 44
2023
Q3
$572K Sell
5,555
-1,115
-17% -$120K 0.44% 48
2023
Q2
$770K Hold
6,670
0.54% 31
2023
Q1
$710K Buy
6,670
+1,115
+20% +$120K 0.56% 30
2022
Q4
$616K Buy
5,555
+1,400
+34% +$143K 0.56% 40
2022
Q3
$358K Buy
4,155
+1,060
+34% +$94.6K 0.27% 25
2022
Q2
$282K Buy
+3,095
New +$274K 0.18% 39

Other funds holding MRK

Alpha Family Trust's MRK Position: Q1 2026 in Review

Alpha Family Trust held its Merck (MRK) position steady in Q1 2026 at 5,975 shares worth $719K. The position accounts for 0.35% of the portfolio, ranked #47.

Alpha Family Trust first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $770K in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alpha Family Trust held 5,975 shares of Merck worth $719K as of Q1 2026.
  • Alpha Family Trust left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.35% of Alpha Family Trust's portfolio in Q1 2026, its #47 holding.
  • Alpha Family Trust first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Alpha Family Trust's Merck position peaked at $770K in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.